silybin has been researched along with Acute Lung Injury in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
AbouZid, SF; Ahmed, OM; Ali, TM; Almoiliqy, M; An, S; Anggraeni, AT; Bailón-García, E; Bueno-López, A; Buyze, J; Chen, DQ; Chen, X; Davó-Quiñonero, A; De Weggheleire, A; Ding, Z; El-Kalaawy, AM; Elesawy, BH; Francque, S; Gao, F; Guo, Y; Juan-Juan, J; Li, S; Li, Y; Lin, Y; Liu, X; Liu, Z; Lozano-Castelló, D; Lu, X; Lynen, L; Meng, Q; Peng, J; Ran, Y; Razali, MH; Rodríguez, SL; Shen, MJ; Soedarsono, S; Soeprijanto, B; Su, W; Sun, P; Tang, AL; Thai, S; Tian, G; Topîrceanu, A; van Griensven, J; Wang, H; Wang, Y; Wen, J; Xi, J; Xiong, MC; Yang, S; Yang, X; Yassin, NYS; Ye, L; Yusoff, M; Zhang, GQ; Zhang, Y | 1 |
Cao, S; Wang, B; Wang, Y; Wu, D; Zhang, B | 1 |
Li, W; Tian, L; Wang, T | 1 |
Gong, T; Liao, L; Peng, Q; Sun, X; Zhang, L; Zhang, Q; Zhang, X; Zhou, J | 1 |
Chung, SY; Kim, JS; Kim, SH; Lee, CG; Lee, HJ; Lee, M; Rho, JK; Shin, IS; Son, Y; Yang, K | 1 |
5 other study(ies) available for silybin and Acute Lung Injury
Article | Year |
---|---|
Topics: Acute Lung Injury; Adherens Junctions; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antigens, CD; Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; beta Catenin; Brain Ischemia; Cadherins; Carcinogenesis; Catalysis; Cell Line; Cells, Cultured; Curcuma; Curcumin; Dioxoles; Disease Models, Animal; Endothelial Cells; Epithelial Cells; Heme Oxygenase (Decyclizing); Humans; Inflammasomes; Intestinal Diseases; Intestinal Mucosa; Ischemic Stroke; Kidney Neoplasms; Lignans; Lung; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; NAD(P)H Dehydrogenase (Quinone); Nanostructures; NF-E2-Related Factor 2; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phytotherapy; Plant Extracts; Pneumonia; PPAR gamma; Proto-Oncogene Proteins c-akt; Pyroptosis; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reperfusion Injury; Respiratory Distress Syndrome; Sepsis; Sesamum; Signal Transduction; Silybin; Silybum marianum; Silymarin; Sirtuin 3; Titanium; Transfection; Treatment Outcome; White Matter | 2021 |
Silybin attenuates LPS-induced lung injury in mice by inhibiting NF-κB signaling and NLRP3 activation.
Topics: Acute Lung Injury; Animals; Cell Line; Cytokines; Disease Models, Animal; Female; Humans; Inflammasomes; Inflammation Mediators; Lipopolysaccharides; Mice; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Phosphorylation; Reactive Oxygen Species; Signal Transduction; Silybin; Silymarin | 2017 |
Therapeutic effects of silibinin on LPS-induced acute lung injury by inhibiting NLRP3 and NF-κB signaling pathways.
Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Cytokines; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred BALB C; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Peroxidase; Plant Extracts; Signal Transduction; Silybin; Silybum marianum; Silymarin | 2017 |
Hepatitis B virus preS1-derived lipopeptide functionalized liposomes for targeting of hepatic cells.
Topics: Acute Lung Injury; Animals; Antioxidants; HeLa Cells; Hepatitis B Surface Antigens; Humans; Liposomes; Male; Mice; Mice, Inbred ICR; Molecular Targeted Therapy; Nanocapsules; Nanocomposites; Particle Size; Protein Precursors; Silybin; Silymarin; Treatment Outcome | 2014 |
The ameliorative effect of silibinin against radiation-induced lung injury: protection of normal tissue without decreasing therapeutic efficacy in lung cancer.
Topics: Acute Lung Injury; Administration, Oral; Animals; Antioxidants; Dose-Response Relationship, Drug; Female; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Radiation Injuries, Experimental; Silybin; Silybum marianum; Silymarin | 2015 |